Business
Press Release Jan 27 2026
The Company has informed the Exchange regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP.
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" The Company has informed the Exchange regarding receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the ANDA Methylprednisolone Acetate Injectable Suspension USP. View Attachment","length":353,"tagName":"div"}]